Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Zeneca patents new class of DNA gyrase-inhibiting antibiotics

Feb. 11, 1999

Biota's inhaled influenza drug recommended for approval in Australia

Feb. 10, 1999

Trovan I.V. potentially incompatible with normal saline and lactated Ringer's solutions

Feb. 10, 1999

New antibacterial series produced by Streptomyces discovered by Kyowa Hakko

Feb. 10, 1999

Status update for OPB-2045

Feb. 9, 1999

Oxazolidinones from P&U with broad-spectrum antibacterial activity

Feb. 9, 1999

New antiviral agents from SB for herpesvirus infections

Feb. 9, 1999

Novel semisynthetic macrolide antibiotics developed at Abbott

Feb. 5, 1999

Pediatric use of Maxipime approved by the FDA

Feb. 3, 1999

9a-Azalides with potent antibacterial activity in development at Merck

Feb. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...